← Back to headlines
Halozyme Projects Over $1B in ENHANZE Royalties by 2026, Announces $1B Share Buyback
Halozyme Therapeutics has outlined projections for its ENHANZE royalties to exceed $1 billion by 2026 and announced a new $1 billion share buyback program.
12 May, 02:53 — 12 May, 02:53
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
3h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
10h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
13h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
21h ago